Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 25, 2026

Robot-assisted Partial Splenectomy
08:34

Robot-assisted Partial Splenectomy

Published on: January 2, 2026

Primary splenic angiosarcoma.

Zengjun Liu1, Xuefei Du, Hongtao Li

  • 1Shanghai No. 6 Hospital, Shanghai, China.

VASA. Zeitschrift Fur Gefasskrankheiten
|January 17, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated volatile and non-volatile metabolomics reveal aroma chemotypes in Capsicum cultivars.

Food chemistry: X·2026
Same author

Development of potent BChE/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis.

European journal of medicinal chemistry·2026
Same author

Repeatability and agreement of planar lumbar range of motion measured by dynamic fluoroscopy and optical motion capture in an ovine cadaveric model.

Frontiers in bioengineering and biotechnology·2026
Same author

[Clinical characteristics of Lingnan acupuncture for depression based on the theory of "treating and regulating the mind"].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2026
Same author

A three-pronged strategy with minimalist nattokinase nanocomposite eye drops breaks the vicious cycle in ultraviolet-B-induced cataract.

Journal of nanobiotechnology·2026
Same author

Anti-adenylate kinase 5 encephalitis: Case series and review of <sup>18</sup>F-DPA714 PET/MRI radiographic changes.

Journal of neuroimmunology·2026

Primary splenic angiosarcoma is a rare, aggressive cancer with poor prognosis. This case study highlights an exceptional nine-year symptom-free survival following early splenectomy alone, challenging typical outcomes.

Area of Science:

  • Oncology
  • Surgical Pathology
  • Soft Tissue Sarcoma Research

Background:

  • Primary angiosarcoma of the spleen is an exceptionally rare and aggressive malignancy.
  • This soft tissue sarcoma is characterized by early dissemination and a typically dismal prognosis.
  • Mean survival rates are generally one to two years post-diagnosis.

Observation:

  • A unique case of primary splenic angiosarcoma is presented.
  • The patient underwent splenectomy alone during the early phase of the disease.
  • Remarkably, the patient remained asymptomatic for an extended nine-year period.

Findings:

  • The presented case demonstrates prolonged, uncommonly symptom-free survival.
  • Early surgical intervention (splenectomy) may be associated with improved long-term outcomes in select cases.

More Related Videos

Application of Microwave Ablation in Laparoscopic Partial Splenectomy
03:49

Application of Microwave Ablation in Laparoscopic Partial Splenectomy

Published on: November 15, 2024

Related Experiment Videos

Last Updated: May 25, 2026

Robot-assisted Partial Splenectomy
08:34

Robot-assisted Partial Splenectomy

Published on: January 2, 2026

Application of Microwave Ablation in Laparoscopic Partial Splenectomy
03:49

Application of Microwave Ablation in Laparoscopic Partial Splenectomy

Published on: November 15, 2024

  • This finding contrasts with the generally poor prognosis associated with splenic angiosarcoma.
  • Implications:

    • This case suggests that early splenectomy alone might offer a better prognosis than previously understood for primary splenic angiosarcoma.
    • Further research into prognostic factors and optimal management strategies for this rare sarcoma is warranted.
    • Highlights the importance of individualized treatment approaches in rare oncological conditions.